Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient

Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is a newer and effective therapeutic option approved for patients with relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Acute kidney injury is a complication of CAR T-cell therapy that can result in kidney fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Melilli, Edoardo, Mussetti, Alberto, Linares, Gabriela Sanz, Ruella, Marco, La Salette, Charette, Savchenko, Alexandre, Taco, Maria del Rosario, Montero, Nuria, Grinyo, Josep, Fava, Alex, Gomà, Montse, Meneghini, Maria, Manonelles, Anna, Cruzado, Josepmaria, Sureda, Ana, Bestard, Oriol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350835/
https://www.ncbi.nlm.nih.gov/pubmed/34401733
http://dx.doi.org/10.1016/j.xkme.2021.03.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350835/
https://www.ncbi.nlm.nih.gov/pubmed/34401733
http://dx.doi.org/10.1016/j.xkme.2021.03.011

Ejemplares similares